ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
- PMID: 35654870
- DOI: 10.1007/s10495-022-01736-x
ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
Abstract
Esophageal squamous cell carcinoma (ESCC) is a common digestive cancer with high mortality rate due to late diagnosis and drug resistance. It is important to identify new molecular target and develop new anticancer strategy. ML323 is a novel USP1 inhibitor and exhibits anticancer activity against several cancers. Herein, we investigated whether ML323 has some cytotoxity effect on ESCC cells and explored the underlying mechanisms. Results revealed that ML323 impeded esophageal cancer cell viability and colony formation. Meanwhile, ML323 blocked cells at G0/G1 phase concomitant with the reduced protein level of c-Myc, cyclin D1, CDK4 and CDK6. ML323 treatment also triggered DNA damage and active p53. Then, ML323 induced apoptosis by p53-Noxa. Additionally, it stimulated protective autophagy. Co-treatment with CQ or BafA1, two classical autophagy inhibitors, enhanced the cytotoxity of ML323. These findings suggested that USP1 inhibitor (ML323) could be used as a viable anti-ESCC approach.
Keywords: Apoptosis; Autophagy; Cell cycle arrest; Esophageal squamous cell carcinoma; ML323.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma.Cell Biol Toxicol. 2023 Oct;39(5):2011-2032. doi: 10.1007/s10565-021-09686-x. Epub 2022 Jan 13. Cell Biol Toxicol. 2023. PMID: 35022897
-
Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.Eur J Med Res. 2024 May 22;29(1):293. doi: 10.1186/s40001-024-01882-9. Eur J Med Res. 2024. PMID: 38773551 Free PMC article.
-
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.J Transl Med. 2017 Jun 2;15(1):127. doi: 10.1186/s12967-017-1231-7. J Transl Med. 2017. PMID: 28578693 Free PMC article.
-
Discovery of ML323 as a Novel Inhibitor of the USP1/UAF1 Deubiquitinase Complex.2012 Oct 23 [updated 2014 Sep 18]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2012 Oct 23 [updated 2014 Sep 18]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 25506968 Free Books & Documents. Review.
-
Anticancer properties and mechanism insights of α-hederin.Biomed Pharmacother. 2023 Sep;165:115205. doi: 10.1016/j.biopha.2023.115205. Epub 2023 Jul 25. Biomed Pharmacother. 2023. PMID: 37499451 Review.
Cited by
-
Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation.Cell Death Dis. 2023 Nov 27;14(11):776. doi: 10.1038/s41419-023-06317-7. Cell Death Dis. 2023. PMID: 38012162 Free PMC article.
-
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.Viruses. 2023 Feb 28;15(3):655. doi: 10.3390/v15030655. Viruses. 2023. PMID: 36992362 Free PMC article.
-
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC.Cells. 2024 Oct 30;13(21):1798. doi: 10.3390/cells13211798. Cells. 2024. PMID: 39513905 Free PMC article.
-
LncRNA OLMALINC promotes osteosarcoma progression through USP1-mediated autophagy suppression.Hum Cell. 2025 Apr 18;38(3):91. doi: 10.1007/s13577-025-01221-y. Hum Cell. 2025. PMID: 40249458
-
Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer.Oncol Res. 2024 Dec 20;33(1):213-224. doi: 10.32604/or.2024.046895. eCollection 2025. Oncol Res. 2024. PMID: 39735674 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous